COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

TVNET3 October 28, 2021 12:53 pm

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

19,631 Articles (15,121 medRxiv, 4,510 bioRxiv)

Most recent first Page 1: Articles 1-10  | Next

Regional probabilistic situational awareness and forecasting of COVID-19

Engebretsen, S., Palomares, A. D.-L., Rø, G. Øvind I., Kristoffersen, A. B., Lindstrøm, J. C., Engø-Monsen, K., Chan, L. Y. H., Dale, Ørjan, Midtbø, J. E., Lindalen-Stenerud, K., Di Ruscio, F., White, R. A., Frigessi, A., de Blasio, B. F.

10.1101/2021.10.25.21265166 — Posted: 2021-10-27

Safety Monitoring of mRNA Vaccines Administered During the Initial 6 Months of the U.S. COVID-19 Vaccination Program: Reports to Vaccine Adverse Events Reporting System (VAERS) and v-safe

Rosenblum, H. G., Gee, J. M., Liu, R., Marquez, P. L., Zheng, B., Strid, P., Abara, W. E., McNeil, M. M., Myers, T. R., Hause, A. M., Su, J. R., Baer, B., Menschik, D., Markowitz, L. E., Shimabukuro, T. T., Shay, D. K.

10.1101/2021.10.26.21265261 — Posted: 2021-10-27

The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New Zealand

McGregor, R., Craigie, A. K., Jack, S., Upton, A., Moreland, N. J., Ussher, J.

10.1101/2021.10.26.21265501 — Posted: 2021-10-27

Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19

Baker, J. R., Mahdi, M., Nicolau, D. V., Ramakrishnan, S., Barnes, P. J., Simpson, J. L., Cass, S., Russell, R. E. K., Donnelly, L. E., Bafadhel, M.

10.1101/2021.10.26.21265512 — Posted: 2021-10-27

Mobility network reveals the impact of geographic vaccination heterogeneity on COVID-19

Yuan, Y., Jahani, E., Zhao, S., Ahn, Y.-Y., Pentland, A. S.

10.1101/2021.10.26.21265488 — Posted: 2021-10-27

Boosting of the SARS-CoV-2-specific immune response after vaccination with single-dose Sputnik Light vaccine

Komissarov, A., Dolzhikova, I., Efimov, G., Logunov, D., Mityaeva, O., Molodtsov, I., Naigovzina, N., Peshkova, I., Shcheblyakov, D., Volchkov, P., Vasilieva, E.

10.1101/2021.10.26.21265531 — Posted: 2021-10-27

Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals

Jeewandara, C., Aberathna, I., Gomes, L., Pushpakumara, P., Danasekara, S., Guruge, D., Ranasinghe, T., Gunasekara, B., Kamaladasa, A., Kuruppu, H., Somathilaka, G., Dissanayaka, O., Gamalath, N., Ekanayaka, D., Jayamali, J., Jayathilaka, D., Mudunkotuwa, A., Harvie, M., Nimasha, T., Wijayamuni, R., Schimanski, L., Rijal, P., Tan, T., Tong, T., Townsend, A., Ogg, G., Malavige, G. N.

10.1101/2021.10.27.21265561 — Posted: 2021-10-27

Deep autoencoder enables interpretable tissue-adaptive deconvolution and cell-type-specific gene analysis

Chen, Y., Wang, Y., Chen, Y., Wei, Y., Li, Y., Chan, T.-F., Li, Y.

10.1101/2021.10.26.465846 — Posted: 2021-10-27

Excessive inflammatory and metabolic responses to acute SARS-CoV-2 infection are associated with a distinct gut microbiota composition

Albrich, W. C., Ghosh, T. S., Ahearn-Ford, S., Mikaeloff, F., Lunjani, N., Forde, B., Suh, N., Kleger, G.-R., Pietsch, U., Frischknecht, M., Garzoni, C., Forlenza, R., Horgan, M., Sadlier, C., Negro, T. R., Pugin, J., Wozniak, H., Cerny, A., Neogi, U., O’Toole, P. W., O’Mahony, L.

10.1101/2021.10.26.465865 — Posted: 2021-10-26

Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort – EPICOV

WARSZAWSKI, J., Meyer, L., Franck, J.-E., Rahib, D., Lydie, N., Gosselin, A., Counil, E., Kreling, R., Novelli, S., Slama, R., Raynaud, P., Bagein, G., Costemalle, V., Sillard, P., Fourie, T., de Lamballerie, X., Bajos, N., EpiCov Study Group

10.1101/2021.10.25.21265456 — Posted: 2021-10-26

Category: News